Novel Gene Therapy for Vision Loss Experiment to Fly to ISS

Will Research Treatments for Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a leading cause of blindness in older adults, affecting more than 200 million people globally. Patients in the intermediate stage of the disease currently lack an effective treatment to improve vision or slow disease progression. Now, a new gene therapy from biotech innovator Oculogenex, Inc. may change that nar…